Strategic Acquisition Pharma Start is now part of Firma Clinical Research, signaling potential cross-sell opportunities to an established CRO with broad capabilities in in-home patient visits, data management, biostatistics, regulatory consulting, and clinical operations.

Quality Certification Firma Clinical Research holds ISO 9001:2015 certification, which can be leveraged to position services for pharma and biotech sponsors seeking compliant, scalable, and quality-driven clinical trial operations.

Mid-market Focus Pharma Start’s small-to-mid-sized team and revenue range suggest a target profile for mid-tier pharma/biotech sponsors looking for flexible, cost-efficient partnerships without the complexity of large CROs.

Full-Service Potential With capabilities spanning clinical pharmacology, data management, biostatistics, medical writing, regulatory consulting, and clinical operations, there are multiple cross-sell avenues for expanding service lines with existing clients.

Competitive Positioning Compared to large CROs, Pharma Start offers a leaner, potentially faster-velocity engagement model; emphasize speed, personalized service, and in-home patient visit capabilities to win projects from bigger competitors.